Speed Medical results, Q2 2025
Net profit, assets, equity and cash flow for Q2 2025, against the same period a year earlier, from the published financial statements.
Net profit-16.74 millionEGP · +22.2% vs the same period a year earlier
Operating cash flow-8.75 millionEGP · −1793.8% vs the same period a year earlier
In short
- Speed Medical's net profit for Q2 2025 was about -16.74 million EGP, up +22.2% from -21.51 million EGP in Q2 2024.
- Operating cash flow for Q2 2025 was negative at 8.75 million EGP.
Key lines against the same period a year earlier
This periodQ2 2024Change
Net profit-16.74 million-21.51 million+22.2%
Gross profit544 thousand-4.78 million+111.4%
Total assets—548 million—
Total liabilities—289 million—
Shareholders' equity—258 million—
Total liabilities and equity409 million548 million−25.3%
Operating cash flow-8.75 million517 thousand−1793.8%
Investing cash flow—-13.63 million—
Financing cash flow8.76 million8.48 million+3.4%
Net change in cash11.17 thousand-4.64 million+100.2%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Speed Medical's Q2 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy